Prosecution Insights
Last updated: April 19, 2026

Examiner: BAILEY, STEVEN WILLIAM

Tech Center 2100 • Art Units: 1672 1687 2187

This examiner grants 35% of resolved cases

Performance Statistics

34.8%
Allow Rate
-20.2% vs TC avg
119
Total Applications
+20.8%
Interview Lift
1609
Avg Prosecution Days
Based on 66 resolved cases, 2023–2026

Rejection Statute Breakdown

36.7%
§101 Eligibility
5.6%
§102 Novelty
22.5%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17332904 Machine Learning-Based Analysis of Process Indicators to Predict Sample Reevaluation Success Non-Final OA Illumina, Inc.
17250814 METHODS AND SYSTEMS FOR MONITORING ORGAN HEALTH AND DISEASE Non-Final OA Illumina, Inc.
17135826 METHODS AND SYSTEMS FOR ANALYSIS OF CTCF BINDING REGIONS IN CELL-FREE DNA Final Rejection GUARDANT HEALTH, INC.
17378651 ATTENTION-BASED NEURAL NETWORK TO PREDICT PEPTIDE BINDING, PRESENTATION, AND IMMUNOGENICITY Non-Final OA GENENTECH, INC.
17954340 INCISION SIMULATION DEVICE, INCISION SIMULATION METHOD, AND PROGRAM Non-Final OA FUJIFILM Corporation
17078137 Systems and Methods for Auto-Inoculation in Seed Train and Production Processes Final Rejection Regeneron Pharmaceuticals, Inc.
16653868 MICROSATELLITE INSTABILITY DETERMINATION SYSTEM AND RELATED METHODS Final Rejection TEMPUS AI, INC.
17790869 METHODS AND ARRANGEMENTS TO DESCRIBE DEFORMITY OF A BONE Non-Final OA Smith & Nephew Asia Pacific Pte. Limited
17201501 METHODS FOR ANALYZING SAMPLES Final Rejection SEEGENE, INC.
18747178 DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS Final Rejection Natera, Inc.
17790725 OPTIMIZATION APPARATUS, OPTIMIZATION METHOD, AND PROGRAM Non-Final OA NIPPON TELEGRAPH AND TELEPHONE CORPORATION
17153491 INFORMATION ACQUISITION METHOD USING HEART AND LUNG SOUNDS Non-Final OA UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
18736229 PROTEIN STRUCTURE SEARCH Final Rejection EvolutionaryScale, PBC
17119606 CANCER CLASSIFICATION USING PATCH CONVOLUTIONAL NEURAL NETWORKS Non-Final OA GRAIL, LLC
18583701 HIGH DYNAMIC RANGE DIGITAL QUANTITATION OF TARGETS Final Rejection ENUMERIX, INC.
16789288 TARGETED-PANEL TUMOR MUTATIONAL BURDEN CALCULATION SYSTEMS AND METHODS Final Rejection Tempus Al, Inc.
18387311 SYSTEMS AND METHODS FOR DERIVING AND OPTIMIZING CLASSIFIERS FROM MULTIPLE DATASETS Non-Final OA Inflammatix, Inc.
17774464 METHODS OF DETERMINING ATTRIBUTES OF THERAPEUTIC T CELL COMPOSITIONS Non-Final OA Juno Therapeutics, Inc.
17756625 RANDOM EMULSIFICATION DIGITAL ABSOLUTE QUANTITATIVE ANALYSIS METHOD AND DEVICE Non-Final OA MGI TECH CO., LTD.
17776416 Computational Platform To Identify Therapeutic Treatments For Neurodevelopmental Conditions Non-Final OA STALICLA SA
17257660 INFORMATION PROCESSING DEVICE, INFORMATION PROCESSING SYSTEM, AND PROGRAM Non-Final OA Bayer CropScience K.K.
17914731 SYSTEMS AND METHODS FOR DISTINGUISHING PATHOLOGICAL MUTATIONS FROM CLONAL HEMATOPOIETIC MUTATIONS IN PLASMA CELL-FREE DNA BY FRAGMENT SIZE ANALYSIS Non-Final OA Memorial Sloan Kettering Cancer Center
16975823 Neoantigen Identification with Pan-Allele Models Non-Final OA Gritstone bio,Inc.
17780404 MOLECULAR DATA STORAGE SYSTEMS AND METHODS Non-Final OA TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
17514269 High-Capacity Storage of Digital Information in DNA Non-Final OA EUROPEAN MOLECULAR BIOLOGY LABORATORY
16460051 High-Capacity Storage of Digital Information in DNA Final Rejection EUROPEAN MOLECULAR BIOLOGY LABORATORY
17796826 SYSTEM AND METHOD FOR LEARNING TO GENERATE CHEMICAL COMPOUNDS WITH DESIRED PROPERTIES Non-Final OA 99ANDBEYOND INC.
17860760 Antibody Competition Model Using Hidden Variable Affinities Non-Final OA AbCellera Biologics Inc.
17790183 SYSTEM AND METHOD TO SELECT PHAGE THERAPY BASED ON TIME AND LOCATION Non-Final OA Adaptive Phage Therapeutics, LLC
17436970 METHOD AND SYSTEM FOR PATIENT-SPECIFIC PREDICTING OF CYCLIC LOADING FAILURE OF A CARDIAC IMPLANT Final Rejection FEops NV

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month